Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review

Jeroen S L de Munter, Frank B Hu, Donna Spiegelman, Mary Franz, Rob M van Dam, Jeroen S L de Munter, Frank B Hu, Donna Spiegelman, Mary Franz, Rob M van Dam

Abstract

Background: Control of body weight by balancing energy intake and energy expenditure is of major importance for the prevention of type 2 diabetes, but the role of specific dietary factors in the etiology of type 2 diabetes is less well established. We evaluated intakes of whole grain, bran, and germ in relation to risk of type 2 diabetes in prospective cohort studies.

Methods and findings: We followed 161,737 US women of the Nurses' Health Studies (NHSs) I and II, without history of diabetes, cardiovascular disease, or cancer at baseline. The age at baseline was 37-65 y for NHSI and 26-46 y for NHSII. Dietary intakes and potential confounders were assessed with regularly administered questionnaires. We documented 6,486 cases of type 2 diabetes during 12-18 y of follow-up. Other prospective cohort studies on whole grain intake and risk of type 2 diabetes were identified in searches of MEDLINE and EMBASE up to January 2007, and data were independently extracted by two reviewers. The median whole grain intake in the lowest and highest quintile of intake was, respectively, 3.7 and 31.2 g/d for NHSI and 6.2 and 39.9 g/d for NHSII. After adjustment for potential confounders, the relative risks (RRs) for the highest as compared with the lowest quintile of whole grain intake was 0.63 (95% confidence interval [CI] 0.57-0.69) for NHSI and 0.68 (95% CI 0.57-0.81) for NHSII (both: p-value, test for trend <0.001). After further adjustment for body mass index (BMI), these RRs were 0.75 (95% CI 0.68-0.83; p-value, test for trend <0.001) and 0.86 (95% CI 0.72-1.02; p-value, test for trend 0.03) respectively. Associations for bran intake were similar to those for total whole grain intake, whereas no significant association was observed for germ intake after adjustment for bran. Based on pooled data for six cohort studies including 286,125 participants and 10,944 cases of type 2 diabetes, a two-serving-per-day increment in whole grain consumption was associated with a 21% (95% CI 13%-28%) decrease in risk of type 2 diabetes after adjustment for potential confounders and BMI.

Conclusions: Whole grain intake is inversely associated with risk of type 2 diabetes, and this association is stronger for bran than for germ. Findings from prospective cohort studies consistently support increasing whole grain consumption for the prevention of type 2 diabetes.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Flow Diagram of the Selection…
Figure 1. Flow Diagram of the Selection of Studies for the Meta-Analysis
Figure 2. Forest Plot Showing the Multivariate-Adjusted…
Figure 2. Forest Plot Showing the Multivariate-Adjusted RR of Type 2 Diabetes for a Two-Servings-per-Day Increment in Whole Grain Intake for Individual Cohort Studies and All Studies Combined
Bars and the diamond indicate 95% CIs. The size of the squares corresponds to the weight of the study in the meta-analysis.

References

    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053.
    1. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, et al. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr. 2004;7:147–165.
    1. Jacobs DR, Jr, Marquart L, Slavin J, Kushi LH. Whole-grain intake and cancer: An expanded review and meta-analysis. Nutr Cancer. 1998;30:85–96.
    1. Jacobs DR, Jr, Gallaher DD. Whole grain intake and cardiovascular disease: A review. Curr Atheroscler Rep. 2004;6:415–423.
    1. Liu S, Manson JE, Stampfer MJ, Hu FB, Giovannucci E, et al. A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health. 2000;90:1409–1015.
    1. Meyer KA, Kushi LH, Jacobs DRJ, Slavin J, Sellers TA, et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71:921–930.
    1. Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, et al. Whole-grain intake and the risk of type 2 diabetes: A prospective study in men. Am J Clin Nutr. 2002;76:535–540.
    1. Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr. 2003;77:622–629.
    1. van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR. Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care. 2006;29:2238–2243.
    1. Slavin JL, Martini MC, Jacobs DR, Jr, Marquart L. Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr. 1999;70:459S–463S.
    1. Weickert MO, Mohlig M, Schofl C, Arafat AM, Otto B, et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 2006;29:775–780.
    1. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: A meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050–1056.
    1. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002;76:1191–1201.
    1. Jacobs DR, Jr, Meyer KA, Kushi LH, Folsom AR. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: The Iowa Women's Health Study. Am J Clin Nutr. 1998;68:248–257.
    1. Koh-Banerjee P, Franz M, Sampson L, Liu S, Jacobs DR, et al. Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr. 2004;80:1237–1245.
    1. Willett W, Lenart E. Reproducibility and validity of food-frequency questionnaires. In: Willett W, editor. Nutritional epidemiology, second edition. New York: Oxford University Press; 1998. pp. 101–147.
    1. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, et al. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18:858–867.
    1. National Diabetes Data Group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057.
    1. [No authors listed] Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197.
    1. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 1991;338:774–778.
    1. Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23:991–999.
    1. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1:466–473.
    1. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, et al. Dietary fat and coronary heart disease: A comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149:531–540.
    1. Colditz GA, Hankinson SE. The Nurses' Health Study: Lifestyle and health among women. Nat Rev Cancer. 2005;5:388–396.
    1. Lin DY, Fleming TR, De Gruttola V. Estimating the proportion of treatment effect explained by a surrogate marker. Statist Med. 1997;16:1515–1527.
    1. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309.
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
    1. Stram DO. Meta-analysis of published data using a linear mixed-effects model. Biometrics. 1996;52:536–544.
    1. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
    1. Steffen LM, Jacobs DR, Jr, Murtaugh MA, Moran A, Steinberger J, et al. Whole grain intake is associated with lower body mass and greater insulin sensitivity among adolescents. Am J Epidemiol. 2003;158:243–250.
    1. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr. 2002;76:390–398.
    1. Jensen MK, Koh-Banerjee P, Franz M, Sampson L, Gronbaek M, et al. Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr. 2006;83:275–283.
    1. Liese AD, Roach AK, Sparks KC, Marquart L, D'Agostino RB, Jr, et al. Whole-grain intake and insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Am J Clin Nutr. 2003;78:965–971.
    1. Pereira MA, Jacobs DRJ, Slattery ML, Ruth KJ, Van Horn L, et al. The association of whole grain intake and fasting insulin in a biracial cohort of young adults: The CARDIA study. CVD Prev. 1998;1:231–242.
    1. Sahyoun NR, Jacques PF, Zhang XL, Juan W, McKeown NM. Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr. 2006;83:124–131.
    1. Esmaillzadeh A, Mirmiran P, Azizi F. Whole-grain consumption and the metabolic syndrome: A favorable association in Tehranian adults. Eur J Clin Nutr. 2005;59:353–362.
    1. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, et al. Fiber and magnesium intake and incidence of type 2 diabetes: A prospective study and meta-analysis. Arch Intern Med. 2007;167:956–965.
    1. Hodge AM, English DR, O'Dea K, Giles GG. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care. 2004;27:2701–2706.
    1. Pereira MA, Jacobs DR, Jr, Pins JJ, Raatz SK, Gross MD, et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr. 2002;75:848–855.
    1. Bosello O, Ostuzzi R, Armellini F, Micciolo R, Scuro LA. Glucose tolerance and blood lipids in bran-fed patients with impaired glucose tolerance. Diabetes Care. 1980;3:46–49.
    1. Brodribb AJ, Humphreys DM. Diverticular disease: Three studies. Part III— Metabolic effect of bran in patients with diverticular disease. Br Med J. 1976;1:428–430.
    1. Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, et al. Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care. 2002;25:1522–1528.
    1. Juntunen KS, Laaksonen DE, Poutanen KS, Niskanen LK, Mykkanen HM. High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am J Clin Nutr. 2003;77:385–391.
    1. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, et al. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr. 2003;78:920–927.
    1. Jenkins DJA, Wolever TMS, Taylor RH, Barker HM, Fielden H, et al. Lack of effect of refining on the glycemic response to cereals. Diabetes Care. 1981;4:509–513.
    1. Weickert MO, Mohlig M, Koebnick C, Holst JJ, Namsolleck P, et al. Impact of cereal fibre on glucose-regulating factors. Diabetologia. 2005;8:2343–2353.
    1. US Department of Health and Human Services and US Department of Agriculture. Dietary guidelines for Americans, 2005. 6th edition. 2005. Available: . Accessed 18 July 2007.
    1. Cleveland LE, Moshfegh AJ, Albertson AM, Goldman JD. Dietary intake of whole grains. J Am Coll Nutr. 2000;19:331S–338S.
    1. Lang R, Thane CW, Bolton-Smith C, Jebb SA. Consumption of whole-grain foods by British adults: Findings from further analysis of two national dietary surveys. Public Health Nutr. 2003;6:479–484.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner